MYD88 and B-cell chronic lymphocytic leukemia: Our mutational analysis revealed that KMT2D was the most frequent mutation in CLL patients, which was substantiated by another study by Yi et al., which indicated that the frequency of mutations observed in MYD88 and KMT2D of Chinese CLL patients was higher compared to that observed with Western CLL patients (24).